Modeling interleukin-2-based immunotherapy in AIDS pathogenesis
From MaRDI portal
Publication:1790721
DOI10.1016/J.JTBI.2013.06.019zbMATH Open1397.92334OpenAlexW2028160443WikidataQ42287652 ScholiaQ42287652MaRDI QIDQ1790721FDOQ1790721
Authors: Marcel Joly, D. Odloak 
Publication date: 4 October 2018
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2013.06.019
Recommendations
- Immunotherapy of HIV-1 infection
- Infection dynamics in HIV-specific CD4 T cells: does a CD4 T cell boost benefit the host or the virus?
- Analysis of global dynamics for HIV-infection of CD\(4^+\)T cells and its treatment
- HIV-1 POPULATION DYNAMICSIN VIVO: IMPLICATIONS FOR PATHOGENESIS, EFFECT OF CYTOKINE AND THERAPY STRATEGY
- Modeling CD4\(^+\) T cells dynamics in HIV-infected patients receiving repeated cycles of exogenous Interleukin 7
Cites Work
- The MATLAB ODE Suite
- A model of primary HIV-1 infection
- Dynamics of HIV infection of CD4\(^ +\) T cells
- A model of HIV-1 pathogenesis that includes an intracellular delay
- Mathematical Analysis of HIV-1 Dynamics in Vivo
- Evolutionary game theoretic strategy for optimal drug delivery to influence selection pressure in treatment of HIV-1
- Drug concentration heterogeneity facilitates the evolution of drug resistance
- CXCR4 and CCR5 regulation and expression patterns on T- and monocyte--macrophage cell lineages: Implications for susceptibility to infection by HIV-1
- Host immune responses that promote initial HIV spread
Cited In (6)
- Controlling IL-7 injections in HIV-infected patients
- Immunotherapy of HIV-1 infection
- T cell and reticular network co-dependence in HIV infection
- Title not available (Why is that?)
- Modeling CD4\(^+\) T cells dynamics in HIV-infected patients receiving repeated cycles of exogenous Interleukin 7
- Modeling the role of IL-2 in the interplay between CD4+ helper and regulatory T cells: assessing general dynamical properties
Uses Software
This page was built for publication: Modeling interleukin-2-based immunotherapy in AIDS pathogenesis
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1790721)
